This articleneeds additional citations forverification. Please helpimprove this article byadding citations to reliable sources. Unsourced material may be challenged and removed. Find sources: "Fenoverine" – news ·newspapers ·books ·scholar ·JSTOR(May 2021) (Learn how and when to remove this message) |
You can helpexpand this article with text translated fromthe corresponding article in Italian. (May 2014)Click [show] for important translation instructions.
|
| Clinical data | |
|---|---|
| AHFS/Drugs.com | International Drug Names |
| ATC code | |
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider | |
| UNII | |
| KEGG |
|
| ChEMBL | |
| CompTox Dashboard(EPA) | |
| ECHA InfoCard | 100.048.666 |
| Chemical and physical data | |
| Formula | C26H15N3O3S |
| Molar mass | 449.48 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
Fenoverine (INN) is anantispasmodic [also known as spasmolytics] drug,[1] which acts by inhibiting calcium channels[2] [much in the same way as traditional calcium channel blockers, which are used as antianginal drugs]. In the case of Fenoverine, the relaxation occurs in abdominal / intestinal smooth muscles, while in case of antianginal drugs, the relaxation occurs in coronary vessels. NotablyFenoverine does not act as an antianginal agent.
Fenoverine is known to causerhabdomyolysis.[2][3]
Thisdrug article relating to thegastrointestinal system is astub. You can help Wikipedia byexpanding it. |